New Biologics VP boosts Constructive Bio

Dr Eldridge joins at a pivotal time as the company accelerates its transition from groundbreaking research to impactful commercial solutions.

With over 25 years of expertise in peptides and biologics engineering, Dr Eldridge has a proven track record in drug discovery and development, contributing to the invention of multiple platform technologies and holding numerous patents in the protein and peptide space.

During his career, he has led strategic discovery and development programmes, with a particular focus on harnessing non-natural amino acids – a core area of Constructive Bio’s work.

Dr Eldridge previously served at Isogenica, where he advanced platform technologies and steered product development to market readiness. His appointment underscores Constructive Bio’s commitment to assembling a world-class team capable of transforming cutting-edge science into tangible outcomes.

“Bill’s achievements in developing platform technologies that yield new assets speak for themselves,” said Dr Ola Wlodek, CEO of Constructive Bio.

“He will play a pivotal role in bridging groundbreaking research and commercial success through the development of transformative therapeutic products. We are excited to welcome him to the team and look forward to the impact he will make as we scale our innovations to meet significant industry demand.”

Dr Eldridge added: “Constructive Bio is at the forefront of a biotech revolution. The breakthroughs the team have achieved in genome synthesis are already transforming pharmaceutical manufacturing and will forever change drug discovery. I’m thrilled to help accelerate its commercial applications and create real-world impact.”

This strategic hire comes during an exciting period of rapid growth for Constructive Bio, following its successful Series A funding round of $58 million and the addition of Nobel laureate Sir Greg Winter to its board.

Through exclusive access to breakthrough science from the MRC Laboratory of Molecular Biology, based on the research carried out by founder Professor Jason Chin, Constructive Bio has the ability to rewrite entire genomes and incorporate multiple non-canonical amino acids in a single molecule.